Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin Huls

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|June 20, 2021
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCTWalter J F M van der Velden, Goda Choi, Moniek A de Witte, et al.
Blood Advances|April 20, 2021
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 yearsIsabelle A van Zeventer, Jonas B Salzbrunn, Aniek O de Graaf, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphomaDiana Al-Sarayfi, Johanna A A Bult, Ruben A L de Groen, et al.
The Journal of Biological Chemistry|April 17, 2004
Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffectedNgoc Hang Le, Paola van der Bent, Gerwin Huls, et al.
Nucleic Acids Research|June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiationFatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Oncoimmunology|January 9, 2018
CD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumabPeter E van Bommel, Yuan He, Ilona Schepel, et al.
Blood Advances|September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clonesRoos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Haematologica|December 20, 2024
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemiaShanna M Hogeling, Duy Minh Lê, Nikita La Rose, et al.
Hemasphere|January 26, 2023
Abnormal Platelet Counts and Clonal Hematopoiesis in the General PopulationPriscilla Kamphuis, Maaike G J M van Bergen, Isabelle A van Zeventer, et al.
Nuclear Medicine Communications|April 20, 2018
Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphomaRayan H M Alkhawtani, Walter Noordzij, Andor W J M Glaudemans, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|June 20, 2021
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCTWalter J F M van der Velden, Goda Choi, Moniek A de Witte, et al.
Blood Advances|April 20, 2021
Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 yearsIsabelle A van Zeventer, Jonas B Salzbrunn, Aniek O de Graaf, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphomaDiana Al-Sarayfi, Johanna A A Bult, Ruben A L de Groen, et al.
The Journal of Biological Chemistry|April 17, 2004
Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffectedNgoc Hang Le, Paola van der Bent, Gerwin Huls, et al.
Nucleic Acids Research|June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiationFatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Oncoimmunology|January 9, 2018
CD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumabPeter E van Bommel, Yuan He, Ilona Schepel, et al.
Blood Advances|September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clonesRoos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Haematologica|December 20, 2024
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemiaShanna M Hogeling, Duy Minh Lê, Nikita La Rose, et al.
Hemasphere|January 26, 2023
Abnormal Platelet Counts and Clonal Hematopoiesis in the General PopulationPriscilla Kamphuis, Maaike G J M van Bergen, Isabelle A van Zeventer, et al.
Nuclear Medicine Communications|April 20, 2018
Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphomaRayan H M Alkhawtani, Walter Noordzij, Andor W J M Glaudemans, et al.
Pageof 17